Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Joining a severe asthma registry speeds the development of targeted therapies by collecting standardized, real-world data on patient characteristics, treatment responses, and long-term outcomes. Participants gain access to cutting-edge research insights, priority consideration for clinical trials, and personalized treatment recommendations.
There are several factors to consider before enrolling, so see below for complete details on how registries work, their benefits, and next steps to guide your healthcare journey.
Severe asthma affects a small but significant portion of people with asthma. It often requires specialized treatments and careful monitoring. By taking part in severe asthma registries, patients and healthcare providers contribute to a richer understanding of the disease and speed the development of new therapies. Below, we explore how registries work, their link to clinical trials registration, and why your involvement matters.
Severe asthma registries are organized databases that collect detailed information on patients whose asthma remains uncontrolled despite high‐level therapy. These registries are typically run by academic research centers, professional medical societies, or health authorities. Their goals include:
By pooling data across clinics, regions, or even countries, registries overcome the limitations of small, single-center studies. They create a real-world evidence base grounded in everyday clinical practice.
Data Standardization and Quality
Registry coordinators use uniform definitions (for example, per Global Initiative for Asthma guidelines) and clear data entry protocols. This ensures that information from different sites can be compared reliably.
Rich Phenotyping
Registries capture not just lung function tests, but also detailed patient histories, allergen sensitivities, blood markers (like eosinophil counts), and quality-of-life measures. This deep phenotyping helps researchers identify subtypes of severe asthma that may respond differently to targeted therapies.
Hypothesis Generation
Large-scale data spur new ideas. For instance, clustering analyses of registry patients have suggested novel mechanisms of airway inflammation, leading to investigational drug programs.
Optimizing Existing Therapies
By observing real-world outcomes, registries can reveal which biologics or add-on treatments work best for particular patient profiles. This information guides physicians in tailoring therapies more effectively.
Clinical trials registration is the process of publicly listing trial details—such as objectives, eligibility criteria, and locations—before a study begins. Registries and clinical trials work hand in hand:
Patient Identification
Severe asthma registries serve as a pool of well-characterized patients. Researchers can screen registry participants for potential enrollment in interventional studies, accelerating recruitment.
Transparency and Trust
Registering trials on publicly accessible platforms (e.g., ClinicalTrials.gov or national equivalents) reduces publication bias and lets patients see all ongoing research. Linking registry data to registered trials ensures that participants know how their information may lead to new therapies.
Regulatory Compliance
Many countries require clinical trials registration to satisfy ethical and legal standards. Registries that collaborate with trial sponsors help streamline approval processes by providing pre-collected baseline data.
Participating in a registry is free for patients and poses no additional clinical risk. Here's what you may gain:
From the researcher's perspective, every new participant enriches the data set, making discoveries more robust and broadly applicable.
Ask Your Specialist
Talk with your pulmonologist, allergist, or asthma specialist. Many centers are already affiliated with national or international registries.
Check Professional Society Websites
Organizations like the European Respiratory Society or American Thoracic Society often list ongoing registry projects and contact details.
Complete the Enrollment Process
You may be asked to provide:
Consent and Data Privacy
You will sign an informed consent form explaining how your data will be used, stored, and shared in de-identified form.
Stay Engaged
Periodic follow-up visits or online surveys keep your information current and enrich the registry's value.
When a trial is registered, you can review key details ahead of time:
This transparency helps you make an informed choice about participation. If you qualify, you might access novel therapies—such as new biologic agents—that are not yet widely available.
Even if you never enroll in a clinical trial, your registry participation can improve your own treatment:
If you're concerned about asthma control or unsure whether your current treatment is adequate, try Ubie's free AI-powered Bronchial Asthma symptom checker to get personalized insights about your respiratory health and discover which symptoms warrant a conversation with your healthcare provider.
Severe asthma can be life-threatening if not managed correctly. Always consult your healthcare provider before making changes to your treatment plan. If you experience:
…seek medical attention promptly. Your participation in severe asthma registries and awareness of clinical trials registration are powerful tools, but they do not replace professional medical advice.
By joining severe asthma registries and staying informed about clinical trials registration, you contribute to a cycle of discovery that benefits both current and future patients. Together, we can accelerate breakthrough science and bring better, more personalized treatments to everyone living with severe asthma.
(References)
* Porsbjerg CM, Buhl R, Dransfield MT, Vest S, Fahrenkamp-Ude K. The Role of Patient Registries in Accelerating Drug Development and Improving Patient Outcomes in Severe Asthma. Adv Ther. 2021 May;38(5):2651-2665. doi: 10.1007/s12325-021-01712-1. Epub 2021 Apr 13. PMID: 33846934; PMCID: PMC8069300.
* Hyland K, Finkelstein J, Lee F. Real-world evidence in severe asthma: Current landscape and future directions. Ann Allergy Asthma Immunol. 2022 Jul;129(1):15-21. doi: 10.1016/j.anai.2022.04.004. Epub 2022 Apr 20. PMID: 35460913.
* McDonald VM, Pavord ID, Nair P, Siddiqui S, Hanania NA. Patient Registries in Severe Asthma: A Systematic Review. J Allergy Clin Immunol Pract. 2020 Jan;8(1):335-343.e1. doi: 10.1016/j.jaip.2019.06.027. Epub 2019 Aug 7. PMID: 31401344.
* Busse WW, Wenzel SE, Buhl R, Castro M, Chupp GL, Dransfield MT, Porsbjerg C, Pugin B, Vest S. Real-World Evidence in Severe Asthma: Current Challenges and Opportunities for Precision Medicine. J Allergy Clin Immunol Pract. 2021 Nov;9(11):4054-4065. doi: 10.1016/j.jaip.2021.09.034. Epub 2021 Sep 24. PMID: 34563821.
* Canonica GW, Pelaia C, Porsbjerg CM. The Role of Patient Registries in Severe Asthma: A Review of Current Use and Future Perspectives. J Clin Med. 2023 Feb 18;12(4):1634. doi: 10.3390/jcm12041634. PMID: 36836254; PMCID: PMC9961125.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.